European Medicines Agency
01.13.21
EMA Receives Conditional Marketing Request for AstraZeneca’s COVID-19 VaccineSource: FirstWord
11.03.20
GenSight Biologics Reports Validation of Lumevoq Marketing Authorization Application (MAA) by European Medicines AgencySource: GenSight Biologics
10.06.20
Samsung Bioepis and Biogen Announce EMA Filing Acceptance of Proposed Lucentis BiosimilarSource: Samsung Bioepis
10.02.20
EMA Starts Rolling Review of AstraZeneca’s COVID-19 Vaccine Candidate AZD1222Source: FirstWord
06.29.20
Novartis Withdraws Marketing Application of Dry Eye Drug Xiidra in EuropeSource: Eyewire News
03.02.20
EMA Grants Two Product Designations to Janssen’s RPGR Gene Therapy for X-Linked Retinitis PigmentosaSource: Janssen
01.02.20
Aerie Pharmaceuticals Announces Acceptance for Review of the Roclanda Marketing Authorization Application in EuropeSource: Aerie Pharmaceuticals
12.16.19
Novartis Receives Positive CHMP Opinion for Beovu (Brolucizumab) for the Treatment of Wet AMDSource: Novartis